T. Rowe Price Associates’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$55.7M Sell
465,999
-1,299,322
-74% -$170M 0.01% 739
2025
Q4
$240M Sell
1,765,321
-754,644
-30% -$109M 0.03% 413
2025
Q3
$372M Sell
2,519,965
-1,237,845
-33% -$172M 0.04% 320
2025
Q2
$486M Buy
3,757,810
+48,847
+1% +$5.92M 0.06% 278
2025
Q1
$443M Buy
3,708,963
+3,239,203
+690% +$401M 0.05% 292
2024
Q4
$54.5M Sell
469,760
-140
-0% -$17.7K 0.01% 727
2024
Q3
$63.5M Buy
469,900
+65,003
+16% +$8.7M 0.01% 689
2024
Q2
$54.9M Buy
404,897
+79,401
+24% +$10.8M 0.01% 694
2024
Q1
$42.1M Buy
325,496
+1,732
+0.5% +$209K 0.01% 770
2023
Q4
$37M Buy
323,764
+8,879
+3% +$886K 0.01% 783
2023
Q3
$28.7M Sell
314,885
-1,300
-0.4% -$134K ﹤0.01% 830
2023
Q2
$35.6M Buy
316,185
+74,087
+31% +$7.84M 0.01% 798
2023
Q1
$25.3M Buy
242,098
+8,058
+3% +$842K ﹤0.01% 852
2022
Q4
$25.9M Sell
234,040
-1,130
-0.5% -$118K ﹤0.01% 846
2022
Q3
$20.5M Buy
235,170
+3,662
+2% +$333K ﹤0.01% 892
2022
Q2
$18.1M Sell
231,508
-22,671
-9% -$1.87M ﹤0.01% 1196
2022
Q1
$21.7M Sell
254,179
-13,857
-5% -$1.33M ﹤0.01% 1211
2021
Q4
$32.1M Sell
268,036
-10,709
-4% -$1.33M ﹤0.01% 1152
2021
Q3
$34.5M Sell
278,745
-5,807
-2% -$747K ﹤0.01% 1139
2021
Q2
$34.1M Sell
284,552
-9,528
-3% -$1.09M ﹤0.01% 1163
2021
Q1
$30.9M Sell
294,080
-650,089
-69% -$65.9M ﹤0.01% 1167
2020
Q4
$96.1M Sell
944,169
-716,727
-43% -$67.4M 0.01% 740
2020
Q3
$140M Sell
1,660,896
-415,076
-20% -$32.3M 0.02% 570
2020
Q2
$135M Sell
2,075,972
-4,106,704
-66% -$271M 0.02% 556
2020
Q1
$403M Sell
6,182,676
-4,225,269
-41% -$333M 0.06% 290
2019
Q4
$820M Sell
10,407,945
-461,715
-4% -$35.9M 0.11% 202
2019
Q3
$865M Buy
10,869,660
+14,194
+0.1% +$1.12M 0.12% 187
2019
Q2
$908M Sell
10,855,466
-1,151,433
-10% -$91.7M 0.13% 175
2019
Q1
$949M Buy
12,006,899
+441,383
+4% +$32.2M 0.14% 158
2018
Q4
$772M Buy
11,565,516
+911,506
+9% +$63.1M 0.13% 160
2018
Q3
$851M Sell
10,654,010
-104,882
-1% -$7.83M 0.12% 181
2018
Q2
$725M Buy
10,758,892
+76,288
+0.7% +$5.54M 0.11% 190
2018
Q1
$822M Buy
10,682,604
+135,831
+1% +$10M 0.13% 178
2017
Q4
$719M Buy
10,546,773
+107,166
+1% +$7.12M 0.12% 187
2017
Q3
$654M Buy
10,439,607
+199,263
+2% +$11.9M 0.11% 197
2017
Q2
$568M Buy
10,240,344
+120,835
+1% +$6.29M 0.1% 220
2017
Q1
$508M Buy
10,119,509
+266,713
+3% +$13M 0.1% 238
2016
Q4
$488M Buy
9,852,796
+21,565
+0.2% +$1.09M 0.1% 239
2016
Q3
$516M Buy
9,831,231
+40,520
+0.4% +$1.99M 0.1% 223
2016
Q2
$437M Buy
9,790,711
+15,620
+0.2% +$679K 0.09% 239
2016
Q1
$400M Sell
9,775,091
-725,636
-7% -$26.7M 0.09% 260
2015
Q4
$383M Sell
10,500,727
-2,498,078
-19% -$90.3M 0.08% 257
2015
Q3
$427M Sell
12,998,805
-4,574,889
-26% -$154M 0.1% 238
2015
Q2
$651M Sell
17,573,694
-413,520
-2% -$15M 0.13% 173
2015
Q1
$630M Sell
17,987,214
-243,405
-1% -$8.59M 0.13% 189
2014
Q4
$694M Buy
18,230,619
+991,210
+6% +$36.3M 0.15% 177
2014
Q3
$612M Buy
17,239,409
+932,351
+6% +$34.6M 0.13% 183
2014
Q2
$637M Buy
16,307,058
+3,582,722
+28% +$134M 0.14% 182
2014
Q1
$463M Buy
12,724,336
+1,795,185
+16% +$65.5M 0.1% 239
2013
Q4
$378M Buy
10,929,151
+1,892,001
+21% +$60.9M 0.09% 277
2013
Q3
$252M Buy
9,037,150
+4,602,500
+104% +$123M 0.06% 356
2013
Q2
$119M Buy
+4,434,650
New +$122M 0.03% 517

Other funds holding XYL

T. Rowe Price Associates's XYL Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Xylem (XYL) stake by 74% in Q1 2026, selling an estimated $170M and leaving 465,999 shares worth $55.7M. The position accounts for 0.01% of the portfolio, ranked #739.

T. Rowe Price Associates first reported a position in XYL in Q2 2013 and has held it in 52 quarters since. The position peaked at $949M in Q1 2019. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • T. Rowe Price Associates held 465,999 shares of Xylem worth $55.7M as of Q1 2026.
  • T. Rowe Price Associates sold 1,299,322 Xylem shares in Q1 2026, an estimated $170M.
  • Xylem made up 0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #739 holding.
  • T. Rowe Price Associates first reported a position in Xylem in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Xylem position peaked at $949M in Q1 2019.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.